Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1468516 | chr14:74360920 | G/A | 1.04E-5 | 176 | 25.4 | 28.3 | 10.43 | KM Plot |
PCPG | rs146888609 | chr7:105147587 | G/A | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs146968304 | chr9:86480677 | T/G | 0.000126 | 175 | 26.57 | 24.7 | 14.47 | KM Plot |
PCPG | rs147065775 | chr7:36162418 | A/C | 0.000461 | 176 | 25.87 | 24.23 | 14.37 | KM Plot |
PCPG | rs147140565 | chr3:53086857 | GA/G | 7.98E-6 | 173 | 25 | 30.87 | 11.78 | KM Plot |
PCPG | rs147234566 | chr3:80451022 | TG/T | 0.000182 | 171 | 25.4 | 25.92 | 22.52 | KM Plot |
PCPG | rs147291849 | chr16:88634271 | G/A | 0.000109 | 171 | 25.53 | 23.53 | 14.47 | KM Plot |
PCPG | rs147366888 | chr8:6733391 | AAAG/A | 9.94E-6 | 173 | 13.27 | 19 | 27.3 | KM Plot |
PCPG | rs147426766 | chr8:121518863 | CTG/C | 4.11E-6 | 178 | 27.23 | 25 | 19.87 | KM Plot |
PCPG | rs147521875 | chr7:158872620 | T/A | 0 | 175 | 25.4 | 41.8 | 3.17 | KM Plot |
PCPG | rs147792551 | chr16:89787968 | C/G | 1.11E-16 | 172 | 25.87 | 20.2 | 3.17 | KM Plot |
PCPG | rs147899617 | chr16:90080352 | C/A | 1.27E-8 | 173 | 25.67 | 20.28 | 6.62 | KM Plot |
PCPG | rs148009429 | chr16:90154346 | A/G | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs148073945 | chr10:69830250 | C/T | 0 | 173 | 25.87 | 21.45 | 2.28 | KM Plot |
PCPG | rs148136030 | chr7:105160628 | G/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |